Monthly Archives: January 2008

Jan Marini Eyelash Product Taken off Market

Jan Marini’s Age Intervention Eyelash Conditioner has been taken off the market after the company ran afoul of FDA regulations regarding its ingredients. At issue here is the fact that the Marini eyelash product contains ingredients similar to those found in prescription drugs for an eye disease. The FDA views the eyelash product as a misbranded drug and therefore a potential threat to consumer safety. In November, the FDA seized thousands of tubes of the popular eyelash product in order to inspect the contents of the product.

Risperdal and Haldol Have No Benefit in Curbing Agressive Behavior, Study Says

In spite of sales that top $10 billion a year, a recent study has found that Haldol and Risperdal have no effect in curbing aggressive behavior of intellectually challenged individuals. In fact, placebos actually fared better than the two highly marketed drugs. Treating aggressive behavior with Haldol and Risperdal is considered off-label usage. Doctors are allowed to determine how and when to treat patients, including using medications for off-label use. However, the problem arises when the pharmaceutical companies begin to promote off-label usage in their marketing campaigns. Risperdal and Haldol have been approved for treatment of schizophrenia but have been used off-label to treat aggressive behavior, depression, and attention deficit disorder.

FDA Issues Warning About Dietary Supplement

The FDA has issued a warning to consumers not to buy or use Super Shangai, Strong Testis, Shangai Ultra, Shangai Ultra X, Lady Shangai, and Shangai Regular (also known as Shangai Chaojimengnan) products. These products are marketed as dietary supplements to treat erectile dysfunction. The problem with the products, according to the FDA news release, concerns the fact that the products contain undeclared active ingredients of FDA-approved prescription drugs for ED. Additionally, the source of the active ingredients is unknown so the safety, effectiveness, or purity of the ingredients can not be known. This is another instance of the FDA having to step in concerning a dietary supplement because it is improperly marketed, made with unknown or unapproved ingredients, or the product label is inaccurate. All of these issues can pose huge safety issues for the consumer.